Prothena Corp Plc
PRTAHealthcare·Biotechnology·Ireland·Small·NASD·Nov 13 • 4:17 AM ET
8.20-0.03 (-0.36%)
2026-11-13 13:12 CET
Market cap
$421.05M
Revenue, TTM
52.73 USD m
Net income, TTM
-23.96 USD m
Free cash flow, TTM
-30.75 USD m
EPS diluted, TTM
-0.47
Price
PRTA against its 20, 50 and 200-day averagesPatternshover a marker to name it
30.5% under the 52-week high of 11.80 on 8 May 2026. 52-week low 7.73 on 11 Jun 2026. Last 15 sessions, 18.8% high to low
Volume 0.00× normal · the line is the 50-bar volume average
Setup. RS line 11
CANSLIM 4 of 6 — fails: 52-Week High/Low: 0-10% below High; Performance: Year +50%
VCP 3 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High
Minervini 0 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 0 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; Average Volume: Over 500K; 52-Week High/Low: 0-10% below High
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 2 of 4 — fails: EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 2 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%) — not on the tape: P/E: Under 25
Value 2 of 4 — fails: Return on Equity: Over +15% — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 1 of 4 — fails: Average Volume: Over 500K; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 1 of 4 — fails: Institutional Transactions: Over +10%; 200-Day Simple Moving Average: Price above SMA200; Performance: Year Up
Relative Strength 0 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200; Average Volume: Over 500K
Profile
PRTA52-week range, 12% of the way up
7.7311.80
Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases. The firm's clinical pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.
| Index | RUT |
|---|---|
| Employees | 67 |
| IPO | Dec 21, 2012 |
| Beta | -0.21 |
| ATR, 14d | 0.43 |
| Rel volume | 0.00 |
| Short float | 18.01% |
| Insider own | 14.46% |
| Inst own | 91.57% |
Snapshot
6 groupsValuation
| Index | RUT |
|---|---|
| Market Cap | $421.05M |
| Enterprise Value | 155.94M |
| Income | -23.96M |
| Sales | 52.73M |
| Book / share | 5.24 |
| Cash / share | 5.28 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 67 |
| IPO | Dec 21, 2012 |
Ratios
| Price / earnings | - |
|---|---|
| Forward price / earnings | - |
| Price / earnings / growth | - |
| Price / sales | 7.99 |
| Price / book | 1.57 |
| Price / cash | 1.55 |
| Price / free cash flow | - |
| Value / cash profit | - |
| Value / sales | 2.96 |
| Quick Ratio | 23.95 |
| Current Ratio | 23.95 |
| Debt / equity | 0.02 |
| Long-term debt / equity | 0.01 |
| Options and short | Yes / Yes |
Earnings
| Earnings / share | -0.47 |
|---|---|
| Earnings next year | -1.02 |
| Earnings next quarter | 0.02 |
| Earnings this year | 99.46% |
| Earnings next year | -4082.30% |
| Earnings growth, 5 years | 62.13% |
| Past earnings growth | -22.46% -10.24% |
| Past sales growth | -43.57% 62.56% |
| Earnings vs last year | 91.00% |
| Sales vs last year | 347.44% |
| Earnings vs last quarter | 52.71% |
| Sales vs last quarter | -74.33% |
| Earnings | Nov 05 AMC |
| Surprise | -40.91% -93.53% |
Ownership
| Insiders own | 14.46% |
|---|---|
| Insider trades | 25.82% |
| Institutions own | 91.57% |
| Institution trades | -2.31% |
| Return on assets | -7.53% |
| Return on equity | -8.50% |
| Return on capital | -8.81% |
| Gross Margin | 92.98% |
| Operating margin | -73.02% |
| Profit Margin | -45.43% |
| 20-day average | -2.60% |
| 50-day average | -4.04% |
| 200-day average | -10.63% |
Technical
| Shares out | 51.34M |
|---|---|
| Shares floating | 43.92M |
| Short / float | 18.01% |
| Short ratio | 17.06 |
| Short interest | 7.91M |
| 52-week high | 11.80 -30.5% |
| 52-week low | 7.73 +6.1% |
| Volatility | 6.46% 5.11% |
| Average range | 0.43 |
| Strength index | 46.27 |
| Market sensitivity | -0.21 |
| Relative volume | 0.00 |
| Avg Volume | 463.81K |
| Volume | 11 |
Performance
| Perf Week | 2.88% |
|---|---|
| Perf Month | -3.53% |
| Perf Quarter | -7.66% |
| Perf Half Y | -15.99% |
| Perf YTD | -14.14% |
| Perf Year | -19.45% |
| Perf 3Y | -75.34% |
| Perf 5Y | -85.66% |
| Perf 10Y | -87.11% |
| Recommendation | 2.00 |
| Target Price | 21.40 |
| Prev Close | 8.23 |
| Price | 8.20 |
| Change % | -0.37% |
Analyst ratings
latest 10 of 20| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| May 28, 2025 | Downgrade | BofA Securities | Neutral → Underperform | $4 | -51.2% |
| May 27, 2025 | Downgrade | Oppenheimer | Outperform → Perform | ||
| May 27, 2025 | Downgrade | Jefferies | Buy → Hold | $6 | -26.8% |
| May 27, 2025 | Downgrade | Cantor Fitzgerald | Overweight → Neutral | ||
| Dec 20, 2024 | Initiated | Chardan Capital Markets | Buy | $40 | +387.8% |
| Jan 30, 2024 | Downgrade | BofA Securities | Buy → Neutral | $68 → $38 | +363.4% |
| Dec 12, 2023 | Initiated | Deutsche Bank | Buy | $62 | +656.1% |
| Apr 24, 2023 | Initiated | SVB Securities | Outperform | $80 | +875.6% |
| Jan 27, 2023 | Initiated | Piper Sandler | Overweight | $94 | +1,046.4% |
| Nov 04, 2022 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform | $52 → $55 | +570.8% |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| ABOS | Acumen Pharmaceuticals Inc | 15.81M |
| ACIU | AC Immune SA | 217.80M |
| KRSA | Korsana Biosciences Inc | 1.42B |
| ALEC | Alector Inc | 381.13M |
| DNLI | Denali Therapeutics Inc | 3.03B |
| CGTX | Cognition Therapeutics Inc | 62.08M |
| AVXL | Anavex Life Sciences Corp | 93.62M |
| ANVS | Annovis Bio Inc | 36.16M |
| VYGR | Voyager Therapeutics Inc | 106.41M |
| ATHE | Alterity Therapeutics Ltd ADR | 40.01M |
Insider trading
latest 14 of 25| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| SCULLY WILLIAM P | 10% Owner | Nov 09 '26 | Buy | 8.53 | 140,000 | 1,194,158 | 977,000 | Nov 10 02:45 PM |
| SCULLY WILLIAM P | 10% Owner | Oct 22 '26 | Buy | 8.19 | 100,000 | 818,520 | 1,137,000 | Oct 26 04:20 PM |
| SCULLY WILLIAM P | 10% Owner | Oct 23 '26 | Buy | 8.07 | 50,000 | 403,525 | 1,187,000 | Oct 26 04:20 PM |
| SCULLY WILLIAM P | 10% Owner | Oct 13 '26 | Buy | 8.35 | 100,000 | 835,480 | 1,027,000 | Oct 15 04:21 PM |
| SCULLY WILLIAM P | 10% Owner | Oct 14 '26 | Buy | 8.46 | 10,000 | 84,569 | 1,037,000 | Oct 15 04:21 PM |
| SCULLY WILLIAM P | 10% Owner | Oct 07 '26 | Buy | 8.40 | 125,000 | 1,050,150 | 439,000 | Oct 09 09:43 AM |
| SCULLY WILLIAM P | 10% Owner | Oct 08 '26 | Buy | 8.57 | 90,000 | 770,904 | 529,000 | Oct 09 09:43 AM |
| SCULLY WILLIAM P | 10% Owner | Oct 02 '26 | Buy | 8.57 | 100,000 | 857,240 | 314,000 | Oct 06 01:53 PM |
| SCULLY WILLIAM P | 10% Owner | Sep 29 '26 | Buy | 8.68 | 162,000 | 1,405,674 | 214,000 | Sep 30 05:10 PM |
| SCULLY WILLIAM P | 10% Owner | Sep 28 '26 | Buy | 8.60 | 103,500 | 889,872 | 187,000 | Sep 29 05:37 PM |
| SCULLY WILLIAM P | 10% Owner | Sep 18 '26 | Buy | 8.43 | 100,000 | 843,460 | 927,000 | Sep 21 04:23 PM |
| SCULLY WILLIAM P | 10% Owner | Sep 02 '26 | Buy | 9.47 | 27,000 | 255,739 | 827,000 | Sep 03 06:23 PM |
| SCULLY WILLIAM P | 10% Owner | Aug 20 '26 | Buy | 8.79 | 50,000 | 439,430 | 800,000 | Aug 21 02:32 PM |
| SCULLY WILLIAM P | 10% Owner | Aug 07 '26 | Buy | 8.62 | 34,000 | 293,053 | 790,000 | Aug 10 03:24 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| IWM | iShares Russell 2000 Index Fund | AUM: 77.86B |
| XBI | State Street SPDR S&P Biotech ETF | AUM: 10.59B |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.79B |
| DFAS | U.S. Small Cap Portfolio-ETF Class Shares | AUM: 15.64B |
| IBB | iShares Biotechnology ETF | AUM: 11.39B |
| VTWO | Vanguard Russell 2000 Index ETF | AUM: 16.90B |
| FSCC | Federated Hermes MDT Small Cap Core ETF | AUM: 503.65M |
| IWO | iShares Russell 2000 Growth ETF | AUM: 14.25B |
| SCHA | Schwab U.S. Small-Cap ETF | AUM: 22.44B |
| DFMC | U.S. Micro Cap Portfolio ETF Class Shares | AUM: 213.58M |
News
latest 14 of 200- Prothena: Q3 Earnings Snapshot (Associated Press) -5.96%
- Prothena Reports Third Quarter 2026 Financial Results and Business Highlights (Business Wire)
- Prothena's Q3 Test: A Shrinking Loss Matters More Than Its Tiny Revenue Line (Earnings Whispers)
- Prothena to Participate in the H.C. Wainwright 28th Annual Global Investment Conference (Business Wire)
- Real Parkinsons Disease Hope from Jupiter Neurosciences (Exec Edge) +6.66%
- Prothena: Q2 Earnings Snapshot (Associated Press)
- Prothena Reports Second Quarter 2026 Financial Results and Business Highlights (Business Wire)
- Prothena to Report Second Quarter 2026 Financial Results on August 6 (Business Wire)
- Prothena: Q1 Earnings Snapshot (Associated Press) -5.90%
- Prothena Reports First Quarter 2026 Financial Results and Business Highlights (Business Wire)
- Prothena to Report First Quarter 2026 Financial Results on May 7 (Business Wire)
- Prothena Announces Novo Nordisk Obtains Fast Track Designation from the U.S. FDA for Coramitug (PRX004) in ATTR Amyloidosis with Cardiomyopathy (Business Wire) +6.67%
- Prothena Announces Leadership Team Updates (Business Wire)
- Prothena Partners Present Data Supporting Next Generation Treatments for Parkinsons and Alzheimers Disease at AD/PD 2026 (Business Wire)
Quarterly earnings
2026Q3 EPS -0.320 missed -0.227, from -0.680 a year earlier. Sales 0.62 missed 9.58, from 2.42 a year earlier
The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.
| Period | Reported | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | Surprise | Year-ago quarter | Analysts | Next session |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q3ended 2026-09-30 | 2026-11-05 16:30 | -0.320 | -0.227 | -0.320 | 0.62 | 9.58 | EPS +40.9% · sales -93.5% | vs 2025Q3, year-ago quarter · EPS -52.9% · sales -74.3% | 7 EPS · 6 sales | Open -0.25% vs SPY +0.25%. Close +1.01% vs SPY +0.31% |
| 2026Q2ended 2026-06-30 | 2026-08-06 16:30 | -0.360 | -0.390 | -0.356 | 1.01 | 0.42 | EPS -7.7% · sales +139.5% | vs 2025Q2, year-ago quarter · EPS -84.6% · sales -77.1% | 6 | Open -0.47% vs SPY +0.32%. Close +2.10% vs SPY +0.61% |
| 2026Q1ended 2026-03-31 | 2026-05-07 16:30 | 0.600 | -0.348 | 0.605 | 51.08 | 0.81 | EPS -272.3% · sales +6215.2% | vs 2025Q1, year-ago quarter · EPS -153.6% · sales +1706.4% | 6 EPS · 5 sales | Open +4.56% vs SPY +0.46%. Close +2.00% vs SPY +0.83% |
| 2025Q4ended 2025-12-31 | 2026-02-19 16:30 | -0.400 | -0.559 | -0.401 | 0.02 | 1.33 | EPS -28.4% · sales -98.4% | vs 2024Q4, year-ago quarter · EPS -63.0% · sales -99.0% | 7 | Open +3.88% vs SPY -0.32%. Close -0.11% vs SPY +0.72% |
| 2025Q3ended 2025-09-30 | 2025-11-06 16:30 | -0.680 | -0.687 | -0.679 | 2.42 | 6.64 | EPS -1.0% · sales -63.6% | vs 2024Q3, year-ago quarter · EPS -38.2% · sales +149.0% | 7 | Open +4.07% vs SPY -0.36%. Close +4.76% vs SPY +0.10% |
| 2025Q2ended 2025-06-30 | 2025-08-04 16:30 | -2.340 | -1.254 | -2.337 | 4.42 | 6.13 | EPS +86.6% · sales -27.9% | vs 2024Q2, year-ago quarter · EPS -291.8% · sales -96.7% | 8 EPS · 7 sales | Open +1.30% vs SPY +0.10%. Close +1.30% vs SPY -0.51% |
| 2025Q1ended 2025-03-31 | 2025-05-08 16:30 | -1.120 | -0.970 | -1.118 | 2.83 | 11.45 | EPS +15.5% · sales -75.3% | vs 2024Q1, year-ago quarter · EPS -16.4% · sales +5556.0% | 8 EPS · 5 sales | Open -1.13% vs SPY +0.25%. Close +4.65% vs SPY -0.13% |
| 2024Q4ended 2024-12-31 | 2025-02-20 16:30 | -1.080 | -1.023 | -1.077 | 2.12 | 7.53 | EPS +5.5% · sales -71.8% | vs 2023Q4, year-ago quarter · EPS -14.3% · sales +571.8% | 9 | Open +4.33% vs SPY -0.04%. Close +2.03% vs SPY -1.71% |
| 2024Q3ended 2024-09-30 | 2024-11-13 08:30 | -1.100 | -1.168 | -1.097 | 0.97 | 1.35 | EPS -5.8% · sales -28.0% | vs 2023Q3, year-ago quarter · EPS -389.5% · sales -98.9% | 8 | Open 0.00% vs SPY +0.08%. Close -0.75% vs SPY +0.05% |
| 2024Q2ended 2024-06-30 | 2024-08-08 16:30 | 1.220 | -1.059 | 1.215 | 132.01 | 10.73 | EPS -215.2% · sales +1130.6% | vs 2023Q2, year-ago quarter · EPS -218.4% · sales +3184.7% | 9 | Open +10.01% vs SPY -0.16%. Close +4.42% vs SPY +0.44% |
| 2024Q1ended 2024-03-31 | 2024-05-08 16:30 | -1.340 | -1.158 | -1.345 | 0.05 | 2.17 | EPS +15.8% · sales -97.7% | vs 2023Q1, year-ago quarter · EPS +50.6% · sales -97.7% | 8 | Open -2.95% vs SPY +0.04%. Close -4.47% vs SPY +0.58% |
| 2023Q4ended 2023-12-31 | 2024-02-15 16:30 | -1.260 | -1.176 | -1.257 | 0.32 | 2.15 | EPS +7.2% · sales -85.3% | vs 2022Q4, year-ago quarter · EPS -1150.0% · sales -99.4% | 9 EPS · 8 sales | Open -0.25% vs SPY -0.06%. Close -1.75% vs SPY -0.50% |
| 2023Q3ended 2023-09-30 | 2023-11-02 16:30 | 0.380 | -0.323 | 0.378 | 84.87 | 41.69 | EPS -217.7% · sales +103.6% | vs 2022Q3, year-ago quarter · EPS -139.2% · sales +5494.3% | 9 | - |
| 2023Q2ended 2023-06-30 | 2023-08-03 16:30 | -1.030 | -0.933 | -1.028 | 4.02 | 5.09 | EPS +10.4% · sales -21.1% | vs 2022Q2, year-ago quarter · EPS +17.0% · sales +206.3% | 9 EPS · 8 sales | - |
| 2023Q1ended 2023-03-31 | 2023-05-04 16:30 | -0.890 | -0.871 | -0.893 | 2.17 | 8.60 | EPS +2.2% · sales -74.8% | vs 2022Q1, year-ago quarter · EPS +14.1% · sales +88.1% | 9 EPS · 7 sales | - |
| 2022Q4ended 2022-12-31 | 2023-02-23 16:30 | 0.120 | -0.466 | 0.118 | 49.92 | 29.14 | EPS -125.8% · sales +71.3% | vs 2021Q4, year-ago quarter · EPS -116.9% · sales +4159.6% | 10 EPS · 9 sales | - |
Annual earnings
2025FY EPS -4.530 beat -4.694, from -2.270 a year earlier. Sales 9.68 missed 10.84, from 135.16 a year earlier
Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.
earnings feed, not the snapshot. Not the statement ratio.
| Period | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | P/E, earnings feed |
|---|---|---|---|---|---|---|
| 2030FYestimate | - | 1.638 | - | - | 236.28 | 5.01 |
| 2029FYestimate | - | -0.482 | - | - | 149.36 | - |
| 2028FYestimate | - | -0.246 | - | - | 101.08 | - |
| 2027FYestimate | - | -1.016 | - | - | 24.54 | - |
| 2026FYestimate | - | -0.024 | - | - | 72.42 | - |
| 2025FY | -4.530 | -4.694 | -4.530 | 9.68 | 10.84 | - |
| 2024FY | -2.270 | -2.214 | -2.275 | 135.16 | 140.55 | - |
| 2023FY | -2.760 | -2.789 | -2.763 | 91.37 | 86.72 | - |
| 2022FY | -2.470 | -3.023 | -2.469 | 53.91 | 43.01 | - |
| 2021FY | 1.380 | 1.311 | 1.382 | 200.58 | 205.49 | 35.80 |
| 2020FY | -2.780 | -2.787 | -2.785 | 0.85 | 0.65 | - |
| 2019FY | -1.950 | -1.978 | -1.948 | 0.81 | 0.86 | - |
| 2018FY | -3.930 | -4.307 | -3.935 | 0.96 | 0.96 | - |
| 2017FY | -4.070 | -4.228 | -4.070 | 27.52 | 27.57 | - |
| 2016FY | -4.660 | -4.365 | -4.660 | 1.06 | 1.14 | - |
| 2015FY | -2.660 | -2.700 | -2.660 | 1.61 | 1.79 | - |
| 2014FY | -0.279 | -0.488 | -0.265 | 50.85 | 50.08 | - |
| 2013FY | -2.200 | -2.090 | -2.200 | 0.68 | 0.67 | - |
| 2012FY | -2.670 | - | -2.840 | 2.66 | - | - |
Quarterly results
2026Q3 revenue 0.62, from 2.42 a year earlier. Operating margin -2,968%, from -1,643% a year earlier
From the quarterly statement. Not an estimate.
Estimate revisions
Latest snapshot of each period and type. 2026FY E -0.02 per share.
| Period | Type | Scale | Date | Mean | vs prior date |
|---|---|---|---|---|---|
| 2026FY | E | per share | 2026-11-06 | -0.02 | -120.5% |
| 2026Q4 | E | per share | 2026-11-06 | 0.02 | -65.3% |
| 2026FY | R | per share | 2026-11-06 | -0.02 | -120.5% |
| 2026Q4 | R | per share | 2026-11-06 | 0.02 | -65.3% |
| 2026FY | S | per share | 2026-11-06 | 72.42 | -12.4% |
| 2026Q4 | S | per share | 2026-11-06 | 19.92 | -23.9% |
| 2026Q3 | E | per share | 2026-10-28 | -0.23 | 0.0% |
| 2026Q3 | R | per share | 2026-10-28 | -0.23 | 0.0% |
| 2026Q3 | S | per share | 2026-10-28 | 9.58 | 0.0% |
| 2026Q2 | E | per share | 2026-08-07 | -0.36 | -8.1% |
| 2026Q2 | R | per share | 2026-08-07 | -0.36 | -8.1% |
| 2026Q2 | S | per share | 2026-08-07 | 0.93 | +119.8% |
| 2026Q1 | E | per share | 2026-05-06 | -0.35 | 0.0% |
| 2026Q1 | R | per share | 2026-05-06 | -0.35 | 0.0% |
| 2026Q1 | S | per share | 2026-03-03 | 0.81 | - |
| 2025Q4 | S | per share | 2026-02-11 | 1.33 | 0.0% |
| 2025FY | E | per share | 2026-02-04 | -4.69 | 0.0% |
| 2025Q4 | E | per share | 2026-02-04 | -0.56 | 0.0% |
| 2025FY | R | per share | 2026-02-04 | -4.69 | 0.0% |
| 2025Q4 | R | per share | 2026-02-04 | -0.56 | 0.0% |
| 2025FY | S | per share | 2026-02-04 | 10.84 | 0.0% |
| 2025Q3 | E | per share | 2025-11-04 | -0.69 | 0.0% |
| 2025Q3 | R | per share | 2025-11-04 | -0.69 | 0.0% |
| 2025Q3 | S | per share | 2025-10-29 | 6.64 | 0.0% |
| 2025Q2 | E | per share | 2025-07-23 | -1.25 | 0.0% |
| 2025Q2 | R | per share | 2025-07-23 | -1.25 | 0.0% |
| 2025Q2 | S | per share | 2025-07-23 | 6.13 | 0.0% |
| 2025Q1 | E | per share | 2025-05-07 | -0.97 | 0.0% |
| 2025Q1 | R | per share | 2025-05-07 | -0.97 | 0.0% |
| 2025Q1 | S | per share | 2025-03-28 | 11.45 | +20.0% |
| 2024Q4 | S | per share | 2025-02-05 | 7.53 | +0.0% |
| 2024FY | S | - | 2025-02-05 | 140.55 | 0.0% |
| 2024FY | E | per share | 2025-02-01 | -2.21 | 0.0% |
| 2024Q4 | E | per share | 2025-02-01 | -1.02 | 0.0% |
| 2024FY | R | per share | 2025-02-01 | -2.21 | 0.0% |
| 2024Q4 | R | per share | 2025-02-01 | -1.02 | 0.0% |
| 2024Q3 | E | per share | 2024-11-01 | -1.18 | -0.1% |
| 2024Q3 | R | per share | 2024-11-01 | -1.18 | -0.1% |
| 2024Q3 | S | per share | 2024-11-01 | 1.22 | -0.3% |
| 2024Q2 | E | per share | 2024-07-23 | -1.06 | 0.0% |
| 2024Q2 | R | per share | 2024-07-23 | -1.06 | 0.0% |
| 2024Q2 | S | per share | 2024-07-23 | 10.73 | 0.0% |
| 2024Q1 | E | per share | 2024-05-01 | -1.16 | 0.0% |
| 2024Q1 | R | per share | 2024-05-01 | -1.16 | 0.0% |
| 2024Q1 | S | per share | 2024-03-11 | 2.17 | +76.8% |
| 2023FY | E | per share | 2024-01-27 | -2.79 | 0.0% |
| 2023FY | R | per share | 2024-01-27 | -2.79 | 0.0% |
| 2023FY | S | per share | 2024-01-27 | 86.72 | 0.0% |
Estimate history
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | MRQ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -4.07 | -3.935 | -1.948 | -2.785 | 1.382 | -2.469 | -2.763 | -2.275 | -4.535 | -0.4737 | - |
| Sales USD millions | 28 | 1 | 1 | 1 | 201 | 54 | 91 | 135 | 10 | 53 | - |
| Shares million shares | 38 | 40 | 40 | 40 | 47 | 52 | 54 | 54 | 54 | - | 51 |
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -1.097 | -1.077 | -1.118 | -2.337 | -0.679 | -0.401 | 0.605 | -0.356 | -0.321 |
| Sales USD millions | 1 | 2 | 3 | 4 | 2 | 0 | 51 | 1 | 1 |
| Shares million shares | 54 | 54 | 54 | 54 | 54 | 54 | 53 | 52 | 51 |
Income statement, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 52.73 | 9.68-92.8% | 135.16+47.9% | 91.37+69.5% | 53.91-73.1% | 200.58+23497.6% | 0.85+4.9% | 0.81-14.7% | 0.95 |
| Cost of Goods Sold Incl. D&A | 3.70 | 3.70+3.1% | 3.59-57.3% | 8.41+24.8% | 6.74 | - | - | - | - |
| Gross Profit | 49.03 | 5.98-95.5% | 131.57+58.6% | 82.96+75.9% | 47.16 | - | - | - | - |
| Selling, General and Administrative Excl. Other | 87.54 | 190.54-33.4% | 286.13+4.4% | 273.99+53.3% | 178.72+46.7% | 121.80+14.2% | 106.61+33.7% | 79.75-43.2% | 140.45 |
| Research and Development | 44.44 | 134.85-39.4% | 222.52+0.9% | 220.57+62.7% | 135.56+64.8% | 82.28+9.9% | 74.88+47.3% | 50.84-49.8% | 101.18 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -38.51 | -184.56 | -154.56 | -191.04 | -131.56-282.8% | 71.97 | -112.73 | -85.76 | -142.71 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unusual Expense | -4.42 | 30.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.06-100.4% | 16.15 |
| Net Income Before Taxes | -23.95 | -200.83 | -128.93 | -160.48 | -125.61-274.7% | 71.92 | -111.43 | -77.30 | -156.12 |
| Income Taxes | 0.02 | 43.26 | -6.62 | -13.45 | -8.66-274.9% | 4.95 | -0.28-173.7% | 0.38 | -0.47 |
| Consolidated Net Income | -23.96 | -244.09 | -122.31 | -147.03 | -116.95-274.6% | 66.98 | -111.14 | -77.68 | -155.65 |
| Net Income From Continuing Operations | -23.96 | -244.09 | -122.31 | -147.03 | -116.95-274.6% | 66.98 | -111.14 | -77.68 | -155.65 |
| Net Income | -23.96 | -244.09 | -122.31 | -147.03 | -116.95-274.6% | 66.98 | -111.14 | -77.68 | -155.65 |
| EPS (Recurring) per share | -0.53 | -4.14 | -2.27 | -2.76 | -2.47-279.0% | 1.38 | -2.78 | -1.95 | -3.65 |
| EPS (Basic, Before Extraordinaries) per share | -0.47 | -4.53 | -2.27 | -2.76 | -2.47-263.6% | 1.51 | -2.78 | -1.95 | -3.93 |
| EPS (Diluted) per share | -0.47 | -4.53 | -2.27 | -2.76 | -2.47-279.0% | 1.38 | -2.78 | -1.95 | -3.93 |
| EBITDA | -34.80 | -180.86 | -150.98 | -182.62 | -124.82-258.4% | 78.78 | -105.76 | -78.94 | -139.49 |
| Non-Operating Income (Expense) | 10.15 | 13.81-46.1% | 25.63-16.1% | 30.56+413.6% | 5.95 | -0.05-103.8% | 1.31-84.4% | 8.40+206.6% | 2.74 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 22.36 | 29.74-18.1% | 36.31+12.3% | 32.32+30.6% | 24.74+14.6% | 21.58+12.0% | 19.26-6.7% | 20.64-12.7% | 23.63 |
| Price To Earnings Ratio ratio statement ratio, not the snapshot | - | - | - | - | - | 35.43 | - | - | - |
| Price To Sales Ratio ratio | 8.17 | 53.08 | 5.51 | 21.17 | 52.94 | 11.94 | 561.99 | 775.59 | 426.66 |
| Gross Margin % | 92.98 | 61.77 | 97.35 | 90.79 | 87.49 | - | - | - | - |
| Operating Margin % | -73.02 | -1,905.82 | -114.36 | -209.08 | -244.05 | 35.88 | -13,216.18 | -10,535.38 | -14,943.46 |
| Net Margin % | -45.43 | -2,520.57 | -90.49 | -160.91 | -216.95 | 33.39 | -13,029.78 | -9,542.63 | -16,297.91 |
| Shares Outstanding million shares | 51.34 | 53.830.0% | 53.83+0.3% | 53.68+3.0% | 52.10+11.7% | 46.66+16.9% | 39.92+0.1% | 39.90+0.1% | 39.86 |
| Market Capitalization | 422.61 | 422.61-43.3% | 745.25-61.8% | 1,950.20-37.3% | 3,110.50+35.1% | 2,301.73+380.1% | 479.46-24.1% | 631.57+53.8% | 410.60 |
Income statement, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.62-74.4% | 1.01-77.1% | 51.08+1704.9% | 0.02-99.1% | 2.42+149.5% | 4.42-96.7% | 2.83+5560.0% | 2.12+562.5% |
| Cost of Goods Sold Incl. D&A | 0.93-1.1% | 0.91+3.4% | 0.92+1.1% | 0.94+3.3% | 0.94+5.6% | 0.88-1.1% | 0.91+2.2% | 0.91-93.6% |
| Gross Profit | -0.31-121.1% | 0.10-97.2% | 50.17+2513.0% | -0.92-176.0% | 1.47+1737.5% | 3.54-97.3% | 1.92 | 1.21 |
| Selling, General and Administrative Excl. Other | 18.09-56.1% | 18.78-66.2% | 24.38-63.9% | 26.29-60.2% | 41.23-38.1% | 55.54-23.6% | 67.50-16.3% | 66.11+2.4% |
| Research and Development | 8.43-70.9% | 8.80-78.3% | 12.63-75.1% | 14.59-70.9% | 28.94-42.9% | 40.52-29.5% | 50.81-20.7% | 50.17-18.9% |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -18.40 | -18.69 | 25.79 | -27.21 | -39.76 | -52.01-189.1% | -65.58 | -64.90 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unusual Expense | 0.42-12.5% | 2.41-92.6% | -4.24 | -3.01 | 0.48 | 32.61 | 0.00 | 0.00 |
| Net Income Before Taxes | -16.51 | -18.58 | 32.72 | -21.58 | -36.91 | -80.97-224.9% | -61.37 | -59.50 |
| Income Taxes | 0.00 | 0.00-100.0% | 0.00 | 0.01 | -0.37 | 44.80 | -1.18 | -1.55 |
| Consolidated Net Income | -16.51 | -18.58 | 32.72 | -21.59 | -36.54 | -125.77-288.0% | -60.20 | -57.96 |
| Net Income From Continuing Operations | -16.51 | -18.58 | 32.72 | -21.59 | -36.54 | -125.77-288.0% | -60.20 | -57.96 |
| Net Income | -16.51 | -18.58 | 32.72 | -21.59 | -36.54 | -125.77-288.0% | -60.20 | -57.96 |
| EPS (Recurring) per share | -0.32 | -0.32 | 0.55 | -0.44 | -0.67 | -1.91-256.6% | -1.12 | -1.08 |
| EPS (Basic, Before Extraordinaries) per share | -0.32 | -0.36 | 0.61 | -0.40 | -0.68 | -2.34-288.7% | -1.12 | -1.08 |
| EPS (Diluted) per share | -0.32 | -0.36 | 0.60 | -0.40 | -0.68 | -2.34-291.8% | -1.12 | -1.08 |
| EBITDA | -17.47 | -17.77 | 26.71 | -26.27 | -38.82 | -51.12-186.2% | -64.67 | -63.98 |
| Non-Operating Income (Expense) | 2.31-30.6% | 2.52-31.0% | 2.69-36.1% | 2.62-51.5% | 3.33-50.1% | 3.65-43.6% | 4.21-40.6% | 5.40-31.6% |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 5.06-11.1% | 6.22-37.9% | 5.46-36.9% | 5.61-32.4% | 5.69-36.9% | 10.02+0.8% | 8.65-11.6% | 8.30-5.4% |
| Price To Sales Ratio ratio | 8.17 | 9.36 | 9.08 | 53.09 | 44.58 | 31.60 | 4.83 | 5.51 |
| Gross Margin % | -50.00 | 9.50 | 98.20 | -4,385.71 | 60.95 | 80.02 | 67.86 | 56.99 |
| Operating Margin % | -2,967.90 | -1,850.20 | 50.49 | -129,576.19 | -1,646.42 | -1,176.63 | -2,318.99 | -3,056.85 |
| Net Margin % | -2,662.74 | -1,839.90 | 64.05 | -102,804.76 | -1,513.08 | -2,845.41 | -2,128.54 | -2,729.91 |
| Shares Outstanding million shares | 51.34-4.6% | 51.74-3.9% | 53.08-1.4% | 53.830.0% | 53.83+0.0% | 53.83+0.1% | 53.83+0.2% | 53.83+0.3% |
| Market Capitalization | 422.61-19.6% | 512.54+56.9% | 523.26-21.4% | 514.08-31.0% | 525.38-41.6% | 326.73-70.6% | 666.11-49.9% | 745.25-61.8% |
Balance sheet, annual
| Metric | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 | 2017FY12/31/2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 307.53-34.8% | 471.39-24.0% | 620.18-12.7% | 710.41+22.7% | 579.09+95.2% | 296.73-21.0% | 375.72-12.1% | 427.66+2.4% | 417.62 |
| Short Term Receivables | 0.00 | 0.00-100.0% | 5.16 | 0.00 | 0.00-100.0% | 0.02-71.4% | 0.07 | 0.00-100.0% | 0.24 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 7.66-45.4% | 14.02+0.6% | 13.94+60.4% | 8.69+51.9% | 5.72+125.2% | 2.54-1.6% | 2.58-30.8% | 3.73-56.0% | 8.47 |
| Total Current Assets | 315.19-35.1% | 485.41-24.1% | 639.28-11.1% | 719.10+23.0% | 584.81+95.4% | 299.28-20.9% | 378.38-12.3% | 431.39+1.2% | 426.33 |
| Net Property, Plant & Equipment | 10.27-25.5% | 13.79-13.8% | 16.00+99.8% | 8.01-43.4% | 14.14-30.6% | 20.36-25.0% | 27.15-48.6% | 52.84-3.9% | 54.99 |
| Total Investments and Advances | 0.860.0% | 0.860.0% | 0.86-61.1% | 2.21+63.7% | 1.350.0% | 1.35-50.0% | 2.70-33.5% | 4.060.0% | 4.06 |
| Intangible Assets | - | - | - | - | - | - | - | - | 0.00 |
| Deferred Tax Assets | 0.00-100.0% | 43.24+27.6% | 33.89+86.2% | 18.20+157.4% | 7.07-39.3% | 11.64+16.9% | 9.96+2.7% | 9.70+19.6% | 8.11 |
| Other Assets | 0.48-87.4% | 3.81-40.0% | 6.35-39.6% | 10.51+425.5% | 2.00+506.1% | 0.33-69.4% | 1.08+33.3% | 0.81-71.5% | 2.84 |
| Total Assets | 326.80-40.3% | 547.11-21.4% | 696.38-8.1% | 758.04+24.4% | 609.37+83.0% | 332.98-20.6% | 419.27-15.9% | 498.80+0.5% | 496.33 |
| Short Term Debt Incl. Current Port. of LT Debt | 2.89+10.7% | 2.61+135.1% | 1.11-82.8% | 6.47+8.9% | 5.94+7.8% | 5.51+8.0% | 5.10 | 0.00 | 0.00 |
| Accounts Payable | 5.88-24.3% | 7.77-69.4% | 25.39+173.9% | 9.27+151.2% | 3.69-10.4% | 4.12+232.3% | 1.24-15.6% | 1.47-89.2% | 13.63 |
| Income Tax Payable | - | - | - | - | 0.00-100.0% | 0.04+300.0% | 0.01-80.0% | 0.05-83.9% | 0.31 |
| Other Current Liabilities | 32.08-15.8% | 38.12+25.4% | 30.39-11.7% | 34.40+44.4% | 23.82+47.2% | 16.18+42.3% | 11.37-15.1% | 13.40-42.8% | 23.43 |
| Total Current Liabilities | 40.84-15.8% | 48.50-14.7% | 56.89+13.4% | 50.15+49.9% | 33.45+29.4% | 25.85+46.0% | 17.71+18.6% | 14.93-60.0% | 37.37 |
| Long Term Debt | 5.49-33.3% | 8.23-23.2% | 10.72 | 0.00-100.0% | 6.39-48.2% | 12.33-30.9% | 17.84 | 0.00 | 0.00 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.00-100.0% | 3.45-94.9% | 67.41-21.5% | 85.85-17.0% | 103.49-6.6% | 110.800.0% | 110.80-31.1% | 160.87+210.7% | 51.77 |
| Total Liabilities | 46.33-23.0% | 60.18-55.4% | 135.02-0.7% | 135.99-5.1% | 143.32-3.8% | 148.97+1.8% | 146.35-16.8% | 175.80+97.2% | 89.14 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 280.47-42.4% | 486.93-13.3% | 561.37-9.8% | 622.04+33.5% | 466.04+153.3% | 184.01-32.6% | 272.92-15.5% | 323.00-20.7% | 407.19 |
| Total Shareholders Equity | 280.47-42.4% | 486.93-13.3% | 561.37-9.8% | 622.04+33.5% | 466.04+153.3% | 184.01-32.6% | 272.92-15.5% | 323.00-20.7% | 407.19 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 280.47-42.4% | 486.93-13.3% | 561.37-9.8% | 622.04+33.5% | 466.04+153.3% | 184.01-32.6% | 272.92-15.5% | 323.00-20.7% | 407.19 |
| Total Liabilities & Stockholders Equity | 326.80-40.3% | 547.11-21.4% | 696.38-8.1% | 758.04+24.4% | 609.37+83.0% | 332.98-20.6% | 419.27-15.9% | 498.80+0.5% | 496.33 |
| Book Value Per Share per share | 5.21-42.4% | 9.05-13.5% | 10.46-12.4% | 11.94+19.5% | 9.99+116.7% | 4.61-32.6% | 6.84-15.6% | 8.10-23.4% | 10.58 |
| Tangible Book Value Per Share per share | 5.21-42.4% | 9.05-13.5% | 10.46-12.4% | 11.94+19.5% | 9.99+116.7% | 4.61-32.6% | 6.84-15.6% | 8.10-23.4% | 10.58 |
| Full-Time Employees people | 67-58.9% | 163-5.8% | 173+36.2% | 127+54.9% | 82+24.2% | 66+29.4% | 51-13.6% | 59-52.8% | 125 |
| Price to Book Ratio ratio | 1.57 | 1.39 | 3.16 | 7.13 | 4.95 | 2.61 | 2.31 | 1.27 | 3.23 |
| Return on Assets % | -55.86 | -19.67 | -20.22 | -17.11 | 14.21 | -29.55 | -16.92 | -31.28 | -32.05 |
| Return on Equity % | -63.62 | -23.34 | -24.85 | -21.50 | 20.61 | -48.65 | -26.07 | -42.63 | -39.67 |
| Return on Invested Capital % | -85.36 | -24.70 | -25.70 | -18.80 | 14.18 | -56.61 | -26.72 | -48.19 | -37.63 |
| Quick Ratio ratio | 7.72 | 10.01 | 11.24 | 14.34 | 17.48 | 11.58 | 21.36 | 28.90 | 11.41 |
| Current Ratio ratio | 7.72 | 10.01 | 11.24 | 14.34 | 17.48 | 11.58 | 21.36 | 28.90 | 11.41 |
Cash flow, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -21.33 | -244.09 | -122.31 | -147.03 | -116.95-274.6% | 66.98 | -111.14 | -77.68 | -155.65 |
| Depreciation | 3.67 | 3.70+3.1% | 3.59-57.3% | 8.41+24.8% | 6.74-0.9% | 6.80-2.6% | 6.98+2.3% | 6.82+111.8% | 3.22 |
| Other Funds (Non Cash) | 21.08 | 37.74-17.9% | 45.96+12.3% | 40.93+30.7% | 31.32+27.0% | 24.66+12.0% | 22.01-6.7% | 23.59-24.6% | 31.29 |
| Funds from Operations | 2.78 | -159.41 | -82.11 | -113.38 | -90.02-187.4% | 103.01 | -83.84 | -48.52 | -122.73 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -32.82 | -4.17 | -67.94 | -20.53 | -18.80 | -10.40-398.9% | 3.48 | -4.45-104.7% | 94.45 |
| Cash from Operating Activities | -30.03 | -163.58 | -150.05 | -133.91 | -108.82-217.5% | 92.61 | -80.36 | -52.97 | -28.28 |
| Capital Expenditures | -0.72 | -0.14 | -0.30 | -2.81 | -0.46 | -0.58 | -0.20 | -0.56 | -1.77 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00-100.0% | 0.04 | 0.00 | 0.00 | 0.00-100.0% | 0.01-75.0% | 0.04 |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -0.72 | -0.14 | -0.30 | -2.77 | -0.46 | -0.58 | -0.20 | -0.55 | -1.73 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | -26.74 | -0.14-109.0% | 1.55-96.6% | 45.10-81.3% | 241.46+26.9% | 190.33+86413.6% | 0.22-4.3% | 0.23-99.5% | 44.44 |
| Repurchase of Common Pref Stock | -26.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | -0.14 | -0.14-109.0% | 1.55-96.6% | 45.10-81.3% | 241.46+26.9% | 190.33+86413.6% | 0.22-4.3% | 0.23-99.5% | 44.44 |
| Proceedsfrom Stock Options | -0.14 | -0.14 | -0.35-101.5% | 23.58-89.5% | 223.62+27.9% | 174.79 | 0.00 | 0.00-100.0% | 39.76 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | -0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -4.40 |
| Other Financing Activities Uses | -0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -4.40 |
| Cash from Financing Activities | -27.05 | -0.14-109.0% | 1.55-96.6% | 45.10-81.3% | 241.46+26.9% | 190.33+86413.6% | 0.22-4.3% | 0.23-99.4% | 40.04 |
| Net Change in Cash | -57.80 | -163.86 | -148.79 | -91.58-169.3% | 132.17-53.2% | 282.36 | -80.34 | -53.29-630.8% | 10.04 |
| Free Cash Flow | -30.75 | -163.72 | -150.35 | -136.72 | -109.28-218.7% | 92.03 | -80.56 | -53.52 | -30.04 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price to Free Cash Flow ratio | - | - | - | - | - | 26.01 | - | - | - |
| Deferred Taxes & Investment Tax Credit | - | 43.24 | -9.35 | -15.69 | -11.13-343.5% | 4.57 | -1.69 | -1.25 | -1.59 |
Balance sheet, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 271.37-18.0% | 288.19-22.4% | 329.46-21.2% | 307.53-34.8% | 330.84-36.3% | 371.44-34.2% | 417.94-23.7% | 471.39-24.0% |
| Short Term Receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 2.49-72.7% | 3.82-72.8% | 9.74-46.6% | 7.66-45.4% | 9.13-41.9% | 14.04-35.7% | 18.24+1.3% | 14.02+0.6% |
| Total Current Assets | 273.86-19.4% | 292.01-24.2% | 339.20-22.2% | 315.19-35.1% | 339.97-36.5% | 385.48-34.2% | 436.17-22.9% | 485.41-24.1% |
| Net Property, Plant & Equipment | 8.32-26.4% | 9.22-24.7% | 9.35-27.5% | 10.27-25.5% | 11.31-22.8% | 12.25-21.2% | 12.90-20.3% | 13.79-13.8% |
| Total Investments and Advances | 0.860.0% | 0.860.0% | 0.860.0% | 0.860.0% | 0.860.0% | 0.860.0% | 0.860.0% | 0.860.0% |
| Deferred Tax Assets | - | - | - | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | 44.91+22.4% | 43.24+27.6% |
| Other Assets | 0.480.0% | 0.480.0% | 0.48-2.0% | 0.48-87.4% | 0.48-87.2% | 0.48-87.0% | 0.49-86.4% | 3.81-40.0% |
| Total Assets | 283.52-19.6% | 302.58-24.2% | 349.89-29.4% | 326.80-40.3% | 352.63-40.8% | 399.07-38.2% | 495.34-20.5% | 547.11-21.4% |
| Short Term Debt Incl. Current Port. of LT Debt | 3.01+4.5% | 2.96+3.9% | 2.89+9.9% | 2.89+10.7% | 2.88+10.3% | 2.85+10.5% | 2.63+11.0% | 2.61+135.1% |
| Accounts Payable | 1.69-83.9% | 1.94-84.1% | 4.30-73.2% | 5.88-24.3% | 10.50+1.6% | 12.20+31.3% | 16.03+11.2% | 7.77-69.4% |
| Other Current Liabilities | 6.74-82.3% | 6.76-87.2% | 25.33-15.0% | 32.08-15.8% | 38.05+13.6% | 52.76+51.3% | 29.80+12.6% | 38.12+25.4% |
| Total Current Liabilities | 11.43-77.8% | 11.66-82.8% | 32.52-32.9% | 40.84-15.8% | 51.44+10.8% | 67.81+45.1% | 48.46+12.0% | 48.50-14.7% |
| Long Term Debt | 3.25-47.6% | 4.03-41.8% | 4.76-37.2% | 5.49-33.3% | 6.20-30.2% | 6.93-27.4% | 7.58-25.1% | 8.23-23.2% |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.00 | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | 1.62-97.6% | 3.45-94.9% |
| Total Liabilities | 14.68-74.5% | 15.69-79.0% | 37.28-35.3% | 46.33-23.0% | 57.64-5.3% | 74.74+17.4% | 57.66-52.3% | 60.18-55.4% |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 268.84-8.9% | 286.89-11.5% | 312.62-28.6% | 280.47-42.4% | 294.99-44.8% | 324.33-44.3% | 437.68-12.9% | 486.93-13.3% |
| Total Shareholders Equity | 268.84-8.9% | 286.89-11.5% | 312.62-28.6% | 280.47-42.4% | 294.99-44.8% | 324.33-44.3% | 437.68-12.9% | 486.93-13.3% |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 268.84-8.9% | 286.89-11.5% | 312.62-28.6% | 280.47-42.4% | 294.99-44.8% | 324.33-44.3% | 437.68-12.9% | 486.93-13.3% |
| Total Liabilities & Stockholders Equity | 283.52-19.6% | 302.58-24.2% | 349.89-29.4% | 326.80-40.3% | 352.63-40.8% | 399.07-38.2% | 495.34-20.5% | 547.11-21.4% |
| Book Value Per Share per share | 5.24-4.4% | 5.54-8.1% | 5.89-27.6% | 5.21-42.4% | 5.48-44.8% | 6.03-44.3% | 8.13-13.0% | 9.05-13.5% |
| Tangible Book Value Per Share per share | 5.24-4.4% | 5.54-8.1% | 5.89-27.6% | 5.21-42.4% | 5.48-44.8% | 6.03-44.3% | 8.13-13.0% | 9.05-13.5% |
| Full-Time Employees people | - | - | - | 67-58.9% | - | - | - | 163-5.8% |
| Price to Book Ratio ratio | 1.57 | 1.66 | 1.87 | 1.74 | 1.62 | 0.75 | 1.37 | 1.39 |
| Return on Assets % | -7.53 | -12.54 | -35.77 | -55.86 | -59.18 | -58.00 | -19.72 | -19.67 |
| Return on Equity % | -8.50 | -14.39 | -40.30 | -63.62 | -67.63 | -66.85 | -23.46 | -23.34 |
| Return on Invested Capital % | -6.07 | -6.39 | 10.31 | -7.55 | -12.13 | -37.97 | -13.52 | -11.70 |
| Quick Ratio ratio | 23.95 | 25.05 | 10.43 | 7.72 | 6.61 | 5.68 | 9.00 | 10.01 |
| Current Ratio ratio | 23.95 | 25.05 | 10.43 | 7.72 | 6.61 | 5.68 | 9.00 | 10.01 |
Cash flow, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -16.44 | -18.63 | 32.72 | -18.98 | -39.77 | -132.79-298.5% | -60.20 | -55.57 |
| Depreciation | 0.91-9.0% | 0.91-7.1% | 0.92+1.1% | 0.93+12.0% | 1.00+7.5% | 0.98+10.1% | 0.91+2.2% | 0.83-66.4% |
| Other Funds (Non Cash) | 6.30-18.5% | 6.11-54.1% | 1.72-84.3% | 6.95-26.8% | 7.73-32.8% | 13.30+11.4% | 10.95-11.6% | 9.50-11.5% |
| Funds from Operations | -9.23 | -11.61 | 35.36 | -11.74 | -30.68 | -71.97-193.5% | -50.01 | -47.26 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -2.65 | -13.46-161.6% | -6.48 | -10.23-483.1% | -12.58-626.4% | 21.86 | -3.36 | 2.67-62.0% |
| Cash from Operating Activities | -11.88 | -25.06 | 28.88 | -21.97 | -43.26 | -50.11-409.7% | -53.36 | -44.59 |
| Capital Expenditures | -0.07 | -0.65 | 0.00 | 0.00 | -0.01 | -0.09 | -0.04 | -0.04 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -0.07 | -0.65 | 0.00 | 0.00 | -0.01 | -0.09 | -0.04 | -0.04 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | -4.16 | -15.49 | -6.95 | -0.14 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | -0.10-103.3% |
| Repurchase of Common Pref Stock | -4.16 | -15.49 | -6.95 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 0.00 | 0.00 | 0.00 | -0.14 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | -0.10-103.3% |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | -0.14 | 0.00 | 0.00 | 0.00 | -0.05-101.9% |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | -0.46 | 0.00 | 0.00 | 0.15 | -0.02 | -0.08 | -0.05 | 0.00 |
| Other Financing Activities Uses | -0.46 | 0.00 | 0.00 | 0.15 | -0.02 | -0.08 | -0.05 | 0.00 |
| Cash from Financing Activities | -4.62 | -15.49 | -6.95 | 0.00 | -0.02-105.6% | -0.08-118.2% | -0.05-106.0% | -0.10-433.3% |
| Net Change in Cash | -16.56 | -41.21 | 21.93 | -21.97 | -43.29 | -50.28-405.1% | -53.45 | -44.72 |
| Free Cash Flow | -11.95 | -25.71 | 28.88 | -21.97 | -43.27 | -50.20-413.0% | -53.41 | -44.62 |
Revenue breakdown
USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Collaboration | 135.11 | 9.63 | -92.9% | 99.5% |
| Consolidation, Policy | 0.05 | 0.05 | 0.0% | 0.5% |
| Total | 135.16 | 9.68 | -92.8% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Ireland | 135.16 | 9.68 | -92.8% | 100.0% |
| Total | 135.16 | 9.68 | -92.8% | 100.0% |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 18.01% | 7.9M | 43.9M | 472.26K |
| 2026-10-15 | 18.08% | 7.9M | 43.9M | 486.90K |
| 2026-09-30 | 18.07% | 8.0M | 44.3M | 469.72K |
| 2026-09-15 | 19.12% | 8.5M | 44.7M | 497.34K |
| 2026-08-31 | 19.01% | 8.5M | 44.7M | 524.46K |
| 2026-08-14 | 19.05% | 8.5M | 44.9M | 564.99K |
| 2026-07-31 | 17.91% | 8.2M | 45.6M | 580.81K |
| 2026-07-15 | 17.75% | 8.2M | 46.2M | 542.51K |
| 2026-06-30 | 18.12% | 8.4M | 46.2M | 537.61K |
| 2026-06-15 | 17.03% | 7.9M | 46.2M | 505.87K |
| 2026-05-29 | 16.74% | 7.7M | 46.2M | 527.58K |
| 2026-05-15 | 16.88% | 7.1M | 42.0M | 510.10K |
| 2026-04-30 | 16.31% | 6.9M | 42.1M | 484.52K |
| 2026-04-15 | 16.33% | 7.1M | 43.3M | 509.50K |
| 2026-03-31 | 16.17% | 7.0M | 43.4M | 515.58K |
| 2026-03-13 | 16.24% | 7.0M | 43.4M | 567.78K |
| 2026-02-27 | 15.80% | 6.9M | 43.4M | 571.60K |
| 2026-02-13 | 16.32% | 7.1M | 43.4M | 585.86K |
| 2026-01-30 | 16.28% | 7.1M | 43.4M | 624.11K |
| 2026-01-15 | 16.29% | 7.1M | 43.4M | 622.95K |
Option chain
expiry 2026-11-20| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| call | 1.00 | 5.20 | 8.60 | 0.00 | 0.000 | 0.00 | 0.00 | 0.991 | -0.016 | 0.000 |
| call | 2.00 | 5.30 | 7.60 | 0.00 | 18.788 | 0.00 | 0.00 | 0.955 | -0.095 | 0.001 |
| call | 3.00 | 4.40 | 6.70 | 0.00 | 13.299 | 0.00 | 0.00 | 0.923 | -0.105 | 0.002 |
| call | 4.00 | 2.90 | 5.60 | 0.00 | 9.549 | 0.00 | 0.00 | 0.888 | -0.105 | 0.002 |
| call | 5.00 | 1.90 | 4.60 | 0.00 | 7.422 | 0.00 | 0.00 | 0.847 | -0.100 | 0.003 |
| call | 6.00 | 0.50 | 4.90 | 0.00 | 8.721 | 0.00 | 0.00 | 0.795 | -0.091 | 0.003 |
| call | 7.00 | 0.20 | 4.90 | 1.96 | 9.647 | 5.00 | 0.00 | 0.722 | -0.078 | 0.004 |
| call | 8.00 | 0.30 | 4.90 | 0.40 | 10.368 | 81.00 | 1.00 | 0.658 | -0.142 | 0.004 |
| call | 9.00 | 0.00 | 0.60 | 0.20 | 1.663 | 1,040 | 0.00 | 0.443 | -0.051 | 0.005 |
| call | 10.00 | 0.00 | 0.30 | 0.05 | 1.680 | 42.00 | 0.00 | 0.269 | -0.043 | 0.004 |
| call | 11.00 | 0.00 | 4.90 | 0.00 | 2.181 | 0.00 | 0.00 | 0.228 | -0.051 | 0.004 |
| call | 12.00 | 0.00 | 3.20 | 0.06 | 2.545 | 1.00 | 0.00 | 0.205 | -0.056 | 0.003 |
| call | 13.00 | 0.00 | 0.75 | 0.00 | 2.144 | 0.00 | 0.00 | 0.152 | -0.039 | 0.003 |
| call | 14.00 | 0.00 | 4.90 | 0.00 | 3.142 | 0.00 | 0.00 | 0.178 | -0.063 | 0.003 |
| call | 15.00 | 0.00 | 4.90 | 0.00 | 3.393 | 0.00 | 0.00 | 0.169 | -0.066 | 0.003 |
| call | 16.00 | 0.00 | 4.90 | 0.00 | 3.622 | 0.00 | 0.00 | 0.162 | -0.069 | 0.003 |
| put | 1.00 | 0.00 | 0.05 | 0.00 | 7.940 | 0.00 | 0.00 | -0.009 | -0.015 | 0.000 |
| put | 2.00 | 0.00 | 4.90 | 0.00 | 13.050 | 0.00 | 0.00 | -0.045 | -0.095 | 0.001 |
| put | 3.00 | 0.00 | 4.90 | 0.00 | 9.360 | 0.00 | 0.00 | -0.077 | -0.104 | 0.002 |
| put | 4.00 | 0.00 | 4.90 | 0.00 | 7.111 | 0.00 | 0.00 | -0.112 | -0.104 | 0.002 |
| put | 5.00 | 0.00 | 4.90 | 0.00 | 4.755 | 0.00 | 0.00 | -0.143 | -0.083 | 0.003 |
| put | 6.00 | 0.00 | 4.90 | 0.00 | 3.561 | 0.00 | 0.00 | -0.193 | -0.075 | 0.003 |
| put | 7.00 | 0.00 | 0.80 | 0.00 | 4.550 | 0.00 | 0.00 | -0.271 | -0.117 | 0.004 |
| put | 8.00 | 0.00 | 0.85 | 0.00 | 2.041 | 0.00 | 0.00 | -0.342 | -0.141 | 0.004 |
| put | 9.00 | 0.00 | 4.90 | 0.82 | 9.470 | 1.00 | 0.00 | -0.550 | -0.064 | 0.005 |
| put | 10.00 | 0.00 | 4.90 | 0.00 | 7.643 | 0.00 | 0.00 | -0.735 | -0.043 | 0.004 |
| put | 11.00 | 2.60 | 4.80 | 2.70 | 5.985 | 0.00 | 2.00 | -0.772 | -0.050 | 0.004 |
| put | 12.00 | 3.50 | 4.90 | 0.00 | 4.533 | 0.00 | 0.00 | -0.795 | -0.055 | 0.003 |
| put | 13.00 | 2.40 | 6.90 | 0.00 | 6.998 | 0.00 | 0.00 | -0.810 | -0.058 | 0.003 |
| put | 14.00 | 4.40 | 7.90 | 0.00 | 7.333 | 0.00 | 0.00 | -0.822 | -0.062 | 0.003 |
| put | 15.00 | 5.40 | 8.30 | 0.00 | 6.381 | 0.00 | 0.00 | -0.831 | -0.064 | 0.003 |
| put | 16.00 | 6.40 | 9.00 | 0.00 | 6.010 | 0.00 | 0.00 | -0.838 | -0.067 | 0.003 |
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-11-06 | SEC |
| 2026-11-05 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-09-30 | SEC |
| 2026-11-05 | 8-K | Current report | 2026-11-05 | SEC |
| 2026-10-29 | 8-K | Current report | 2026-10-28 | SEC |
| 2026-10-29 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-27 | SEC |
| 2026-10-26 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-22 | SEC |
| 2026-10-15 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-13 | SEC |
| 2026-10-09 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-07 | SEC |
| 2026-10-06 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-02 | SEC |
| 2026-10-02 | 8-K | Current report | 2026-10-02 | SEC |
| 2026-09-30 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-29 | SEC |
| 2026-09-29 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-28 | SEC |
| 2026-09-21 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-18 | SEC |
| 2026-09-03 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-02 | SEC |
| 2026-08-21 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-20 | SEC |
| 2026-08-19 | SCHEDULE 13G/A | SEC | ||
| 2026-08-18 | 3 | Initial statement of beneficial ownership of securities | 2026-08-18 | SEC |
| 2026-08-18 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-18 | SEC |
| 2026-08-14 | SCHEDULE 13G/A | SEC | ||
| 2026-08-11 | 3 | Initial statement of beneficial ownership of securities | 2026-08-06 | SEC |
| 2026-08-11 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-10 | SEC |
| 2026-08-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-07 | SEC |
| 2026-08-06 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-06-30 | SEC |
| 2026-08-06 | 8-K | Current report | 2026-08-06 | SEC |
| 2026-08-06 | SCHEDULE 13G/A | SEC | ||
| 2026-07-30 | 4 | Statement of changes in beneficial ownership of securities | 2026-07-28 | SEC |
| 2026-07-30 | 4 | Statement of changes in beneficial ownership of securities | 2026-07-28 | SEC |
| 2026-07-30 | 4 | Statement of changes in beneficial ownership of securities | 2026-07-28 | SEC |
| 2026-07-30 | 4 | Statement of changes in beneficial ownership of securities | 2026-07-28 | SEC |
| 2026-07-30 | 4 | Statement of changes in beneficial ownership of securities | 2026-07-28 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 1.19M | 1 | 0 | 0 |
| 2026-10 | 4.82M | 7 | 0 | 0 |
| 2026-09 | 3.39M | 4 | 0 | 0 |
| 2026-08 | 762.65K | 3 | 0 | 0 |
| 2026-07 | 0 | 0 | 135.97K | 2 |
| 2026-06 | 2.12M | 4 | 0 | 0 |
| 2026-05 | 981.30K | 1 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| FMR LLC | 13.66% |
| Rubric Capital Management LP | 9.55% |
| BlackRock, Inc. | 9.30% |
| ACADIAN ASSET MANAGEMENT LLC | 4.03% |
| STATE STREET CORP | 3.59% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.15% |
| D. E. Shaw & Co., Inc. | 3.08% |
| ADAR1 Capital Management, LLC | 2.97% |
| TWO SIGMA INVESTMENTS, LP | 2.42% |
| FEDERATED HERMES, INC. | 2.22% |
Funds
| Fund | % owned |
|---|---|
| Fidelity Growth Company Fund | 4.26% |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | 2.78% |
| iShares Russell 2000 ETF | 2.22% |
| VANGUARD EXPLORER FUND | 1.45% |
| Fidelity Series Growth Company Fund | 1.41% |
| Nuveen Quant Small Cap Equity Fund | 1.21% |
| Fidelity Small Cap Index Fund | 0.93% |
| Select Biotechnology Portfolio | 0.92% |
| VANGUARD EXTENDED MARKET INDEX FUND | 0.92% |
| Fidelity Growth Company K6 Fund | 0.79% |
OakChart. PRTA. Cached 15 minutes. Terms